Safety of blood products and B19 parvovirus;Sécurité des produits sanguins labiles et parvovirus B19

Transfusion Clinique et Biologique

Volumn 13, Issue 4, 2006, Pages 235-241

  Lefrere J J ^a   Maniez Montreuil, M ^b   Morel, P ^b   Defer, C ^b   Laperche, S ^a  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Blood safety; Nucleic Acid Testing; Parvovirus B19

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTICLE; BLOOD COMPONENT; BLOOD COMPONENT THERAPY; BLOOD DONOR; BLOOD TRANSFUSION; DIAGNOSTIC ACCURACY; ERYTHEMA INFECTIOSUM; ERYTHROCYTE LIFESPAN; FETUS DEATH; FETUS HYDROPS; HEMOLYTIC ANEMIA; HUMAN; IMMUNE DEFICIENCY; NUCLEIC ACID ANALYSIS; PARVOVIRUS; PREGNANT WOMAN; SCREENING; SICKLE CELL ANEMIA; VIRUS IMMUNITY;

BLOOD DONORS; BLOOD TRANSFUSION; HUMANS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; SAFETY; VIREMIA;

EID: 33751402158     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2006.03.016     Document Type: Article

References (51)

1. Cossart Y.E., Field A.M., Cant B., and Widdows D. Parvovirus-like particles in human sera. Lancet 1 (1975) 72-73
2. Couroucé A.M., Ferchal F., Morinet F., Perol Y., Drouet J., Muller A., et al. Parvovirus (SPLV) et antigène Aurillac. Rev. Fr. Transf. Immunohémat. 27 (1984) 5-15
3. Paulze A., and Lefrère J.J. De la mort du flamand rose du zoo du Bronx à l'émergence du west nile virus en transfusion sanguine. Hématologie 11 (2005) 117-125
4. Servant A., Laperche S., Lallemand F., Marinho V., De Saint Maur G., Meritet J.F., et al. Genetic diversity within human erythroviruses: identification of three genotypes. J. Virol. 76 (2002) 9124-9134
5. Tri-Nguyen Q., Wong S., Heegaard E.D., and Brown K.E. Identification and characterization of a second novel human erythrovirus variant, A6. Virology 301 (2002) 347-380
6. Brown K.E., Anderson S.M., and Young N.S. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262 (1993) 114-117
7. Von Dem Borne A.E.G., Bos J.E., Joustra-Maas N., Tromp J.F., van't Veer M.B., van Wijngaarden-du Bois R., et al. A murine monoclonal IgM antibody specific for blood group P antigen (globoside). Br. J. Haematol. 63 (1986) 35-46
8. Saito T., Munakata Y., Fu Y., Fujii H., Kodera T., Miyagawa E., et al. Evaluation of anti-parvovirus B19 activity in sera by assay using quantitative polymerase chain reaction. J. Virol. Methods 107 (2003) 81-87
9. Lefrère J.J., Mariotti M., and Thauvin M. B19 parvovirus DNA in solvent-detergent treated anti-hemophiliac concentrates. Lancet 343 (1994) 211-212
10. Brown T., Anand A., Ritchie L.B., Clewley J.P., and Reid T.M. Intra-uterine parvovirus infection associated with hydrops fetalis. Lancet 2 (1984) 1033-1034
11. Pattison J.R., Jones S.E., Hodgson J., Davis L.R., White J.M., Stroud C.E., and Murtaza L. Parvovirus infection and hypoplastic crisis in sickle cell anaemia. Lancet 1 (1981) 664-665
12. Flunker G., Peters A., Wiersbitzky S., Modrow S., and Siedel W. Persistent parvovirus B19 infections in immunocompromised children. Med. Microbiol. Immunol. (Berl.) 186 (1998) 189-194
13. Frickhofen N., Abkowitz J.L., Safford M., Berry J.M., Antunez-de-Mayolo J., Astrow A., et al. Persistent B19 parvovirus infection type 1 (HIV-1): a treatable cause of anaemia in AIDS. Ann. Intern. Med. 113 (1990) 926-933
14. LaMonte A.C., Paul M.E., Read J.S., Frederick M.M., Edrman D.D., Han L.L., et al. Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and uninfected children: the women and infants transmission study. J. Infect. Dis. 189 (2003) 847-851
15. Anderson M.J., Jones S.E., Fisher-Hoch S.P., Lewis E., Hall S.M., Bartlett C.L., et al. Human parvovirus. The cause of erythema infectiosum (fifth disease)?. Lancet 1 (1983) 1378
16. White D.G., Woolf A.D., Mortimer P.P., Cohen B.J., Blake D.R., and Bacon P.A. Human parvovirus arthropathy. Lancet 1 (1985) 419-421
17. Anderson L.J., Higgins P.G., Davies L.R., Willman J.S., Jones S.E., Kidd I.M., et al. Experimental parvovirus infection in humans. J. Infect. Dis. 152 (1985) 257-265
18. Faden H., Gary G.W., and Anderson L.J. Chronic parvovirus infection in a presumably immunologically healthy woman. Clin. Infect. Dis. 15 (1992) 595-597
19. Thomas I., DiGiambatista M., Gérard C., Mathys E., Hougardy C., Latour B., et al. Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins. Vox Sang. 84 (2003) 300-307
20. Candotti D., Etiz N., Parsyan A., and Allain J.P. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J. Virol. 78 (2004) 12169-12178
21. Lefrère J.J., Servant-Delmas A., Candotti D., Mariotti M., Thomas I., Brossard Y., et al. Persistent B19 infection in immunocompetent individuals. Consequences on transfusion safety. Blood 106 (2005) 2890-2895
22. Soderlund-Venermo M., Hokynar K., Nieminen J., Rautakorpi H., and Hedman K. Persistence of human parvovirus B19 in human tissues. Pathol. Biol. 50 (2002) 307-316
23. Nikkari S., Roivainen A., Hannonen P., Mottonen T., Luukkainen R., Yli-Jama T., et al. Persistence of parvovirus B19 in synovial fluid and bone marrow. Ann. Rheum. Dis. 54 (1995) 597-600
24. Lundqvist A., Tolfvenstam T., Bostic J., Söderlund M., and Broliden K. Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow. Scand. J. Infect. 31 (1999) 11-16
25. Foto F., Saag K.G., Scharosch L.L., Howard E.J., and Naides S.J. Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence. J. Infect. Dis. 167 (1993) 744-748
26. Cassinotti P., Burtonboy G., Fopp M., and Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J. Med. Virol. 53 (1997) 229-232
27. Heegaard E.D., Petersen B.L., Heilmann C.J., and Hornsleth A. Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy adults. J. Clin. Microbiol. 40 (2002) 933-936
28. Lee Y.M., Tsai W.H., You J.Y., Kuo B.I.T., Liao P.T., Ho C.K., et al. Parvovirus B19 infection in Taiwanese patients with haematological disorders. J. Med. Virol. 71 (2003) 605-609
29. Modrow S., and Dorsch S. Antibody responses in parvovirus B19 infected patients. Pathol. Biol. 50 (2002) 326-331
30. Cohen B.J., and Buckley M.M. The prevalence of antibody to human parvovirus B19 in England and Wales. J. Med. Microbiol. 25 (1988) 151-153
31. Lefrère J.J., and Couroucé A.M. Human parvovirus infection in France 1984-1986. Lancet 2 (1987) 166-167
32. Lefrère J.J., Boitard P., Couroucé A.M., Lacaze T., and Girot R. Familial human parvovirus infection. Lancet 2 (1985) 333-334
33. Laub R., and Strengers P. Parvoviruses and blood products. Pathol. Biol. 50 (2002) 339-348
34. McOmish F., Yap P.L., Jordan A., Hart H., Cohen B.J., and Simmonds P. Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J. Clin. Microbiol. 31 (1993) 323-328
35. Prowse C., Ludlam C.A., and Yap P.L. Human parvovirus B19 and blood products. Vox Sang. 72 (1997) 1-10
36. Weimer T., Streichert S., Watson C., and Groner A. High-titer screening PCR: a successful strategy for reducing the parvovirus B19 load in plasma pools for fractionation. Transfusion 42 (2001) 1500-1504
37. Brown K.E., Young N.S., and Barbosa L.H. Parvovirus B19: implications for transfusion medicine. Summary of a workshop. Transfusion 41 (2001) 130-135
38. Jordan J., Tiangco B., Kiss J., and Koch W. Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients. Vox Sang. 75 (1998) 97-102
39. Kurtzman G.J., Ozawa K., Cohen B., Hanson G., Oseas R., and Young N.S. Chronic bone marrow failure due to persistent B19 parvovirus infection. N. Engl. J. Med. 317 (1987) 287-294
40. Kurtzman G.J., Cohen B., Meyers P., Amunullah A., and Young N.S. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet 2 (1988) 1159-1162
41. Kurtzman G.J., Frickhofen N., Kimball J., Jenkins D.W., Nienhuis A.W., and Young N.S. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N. Engl. J. Med. 321 (1989) 519-523
42. Weiland H.T., Vermey-Keers C., Salimans M.M., Fleuren G.J., Verwey R.A., and Anderson M.J. Parvovirus B19 associated with foetal abnormality. Lancet 1 (1987) 682-683
43. Pôle des vigilances de l'EFS, communication personnelle ?.
44. Cohen B.J., Beard S., Knowles W.A., Ellis J.S., Joske D., Goldman J.M., et al. Chronic anaemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion. Transfusion 37 (1997) 947-952
45. Zanella A., Rossi F., Cesana C., Foresti A., Nador F., Binda A.S., et al. Transfusion-transmitted human parvovirus B19 infection in a thalassemic patient. Transfusion 35 (1995) 769-772
46. Plentz A., Hahn J., Knoll E., Jilg W., and Modrow S. Exposure of haematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products. Transfusion 45 (2005) 1811-1815
47. Yoto Y., Kudoh T., Haseyama K., Suzuki N., Odat T., Katoh T., et al. Incidence of human parvovirus B19 DNA detection in blood donors. Br. J. Haematol. 91 (1995) 1017-1018
48. Galinella G., Manaresi E., Venturoli S., Grazi G.L., Musiani M., and Zerbini M. Occurrence and clinical role of active parvovirus infection in transplant recipients. Eur. J. Clin. microbial. Infect. Dis. 18 (1999) 811-813
49. Geetha D., Zachary J.B., Baldado H.M., Kronz J.D., and Kraus E.S. Pure red cell aplasia caused by parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature. Clin. Transplant. 14 (2000) 586-591
50. Liefeldt L., Plentz A., Klempa B., Kershaw O., Endres A.S., Raab U., et al. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. J. Med. Virol. 75 (2005) 161-169
51. Anderson L.J., Tsou C., Parker R.A., Chorba T.L., Wulff H., Tattersall P., et al. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 24 (1986) 522-526